BMI Interface Concept Boosts, National Medical Insurance Supports BMI Interface and More Entering Clinical Trials and Charging!
Glorious He 7/31｜BMI interface concept stocks boost, whereupon Innovative Medical (002173) is about to reach a halt, E-Ping Medical (300753) and three more follow suit, including Sibo Brain Science, Entropy Technology, Qisheng Technology, and Yanshan Technology.
On the message front, to support innovative development in pharmaceuticals and medical devices, the National Medical Insurance has formulated a new mechanism for launching prices of newly approved drugs, adding over 100 items related to cutting-edge medical technologies. The guidelines for neurology have unified "BMI interface placement fees" and "BMI interface adaptation fees," allowing BMI interface technology to mature and enter clinical trials after approval, which can then quickly enter clinical applications and charging. Similarly, the guidelines for ear-nose-throat diseases have set up "artificial eardrum implantation fees" and "voice device installation fees" to encourage more patients to "hear and speak." The guidelines for radiation therapy have set up "proton therapy" and "heavy ion therapy" to promote high-end medical equipment's clinical application. At the same time, to encourage pharmaceutical R&D innovation, the National Medical Insurance has also formulated a new mechanism for launching prices of newly approved drugs.